Skip to Content

TEVA 7617 (Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg)

Pill with imprint TEVA 7617 is Yellow, Elliptical / Oval and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 25 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7617

Hydrochlorothiazide and olmesartan medoxomil 25 mg / 40 mg TEVA 7617

Hydrochlorothiazide and Olmesartan Medoxomil

Imprint
TEVA 7617
Strength
25 mg / 40 mg
Color
Yellow
Size
15.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Angiotensin II inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7617
Inactive Ingredients
ferrosoferric oxide, ferric oxide red, ferric oxide yellow, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 3350, polyethylene glycol 4000, sodium lauryl sulfate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.